NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.
About this episode
Arnold Monto discusses the value and feasibility of various methods for evaluating vaccine protection.
Arnold Monto is a professor emeritus of epidemiology and of public health and codirector of the Center for Respiratory Virus Research and Response at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Monto and H.Y. Chu. The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection. N Engl J Med 2026;395:313-316.
People in this episode
Host: Stephen Morrissey
Guest: Arnold Monto
Topics covered
- vaccine evaluation
- public health
- epidemiology
- clinical trials
- observational data
Keywords
- vaccine protection
- epidemiology
- public health
- clinical trials
- observational data
Mentioned in this episode
Organizations: University of Michigan School of Public Health, NEJM
Books & works: The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection, N Engl J Med 2026;395:313-316
More episodes of NEJM Interviews
- NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.
- NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
- NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
- NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
- NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
- NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
Explore listener stats, chart rankings, contacts and more on the NEJM Interviews podcast page.